Clinical Trial Update: Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating propranolol for fainting (syncope) in children with sympathoadrenal imbalance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syncope

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Syncope | Phase 2 | Status: COMPLETED